Trinidad and Tobago Securities and Exchange Commission

Cemtrex’s Vicon Industries Appoints Shane Compton as Chief Operating Officer

Retrieved on: 
목요일, 12월 1, 2022

Brooklyn, NY, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Cemtrex Inc. (Nasdaq: CETX, CETXP) subsidiary Vicon Industries, Inc., a designer and manufacturer of video surveillance and access control software, hardware and components, today announced the appointment of Shane Compton as Chief Operating Officer (COO) at Vicon Industries.

Key Points: 
  • Brooklyn, NY, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Cemtrex Inc. (Nasdaq: CETX, CETXP) subsidiary Vicon Industries, Inc., a designer and manufacturer of video surveillance and access control software, hardware and components, today announced the appointment of Shane Compton as Chief Operating Officer (COO) at Vicon Industries.
  • An accomplished leader in the physical security industry, Compton brings over 20 years of experience as Chief Operations Officer, Chief Technology Officer, and Chief Product Officer at industry-leading companies like Costar Technologies and Pelco.
  • Compton added, It is rare to find a company with such a strong legacy as Vicon.
  • I am thrilled to join Vicon and help lead the Vicon brand to new heights in the industry.

Babcock & Wilcox and Chart Industries to Collaborate on Hydrogen Innovation Utilizing B&W’s BrightLoopTM Technology

Retrieved on: 
목요일, 12월 1, 2022

Babcock & Wilcox (B&W) (NYSE: BW) announced today that it has entered into an agreement with Chart Industries, Inc. (NYSE: GTLS) to collaborate on the further deployment of B&Ws BrightLoopTM hydrogen generation technology, utilizing Charts integrated hydrogen liquefaction and cryogenic carbon capture equipment and expertise.

Key Points: 
  • Babcock & Wilcox (B&W) (NYSE: BW) announced today that it has entered into an agreement with Chart Industries, Inc. (NYSE: GTLS) to collaborate on the further deployment of B&Ws BrightLoopTM hydrogen generation technology, utilizing Charts integrated hydrogen liquefaction and cryogenic carbon capture equipment and expertise.
  • Together, this solution provides economic generation of low-carbon hydrogen and supplies cost-effective, transportable forms of liquid hydrogen and carbon dioxide.
  • B&W and Chart will also work together to develop sales and marketing strategies for potential commercial hydrogen and carbon capture customers and projects.
  • This collaboration agreement with Chart offers tremendous opportunity to further deploy B&Ws advanced BrightLoop technology, said Kenneth Young, Chairman and Chief Executive Officer, B&W.

Comtech to Report First Quarter Fiscal 2023 Results on December 8th

Retrieved on: 
수요일, 11월 30, 2022

November 30, 2022-- Comtech (NASDAQ: CMTL), a leading global provider of next-generation 911 emergency systems and secure wireless communications technologies, today announced that it will report its first quarter of fiscal 2023 results after the market closes on Thursday, December 8, 2022.

Key Points: 
  • November 30, 2022-- Comtech (NASDAQ: CMTL), a leading global provider of next-generation 911 emergency systems and secure wireless communications technologies, today announced that it will report its first quarter of fiscal 2023 results after the market closes on Thursday, December 8, 2022.
  • The company has scheduled an investor conference call for Thursday, December 8, 2022, at 5:00 p.m. Eastern time.
  • Investors are invited to access a live webcast of the conference call from the investor relations section of the Comtech web site at www.comtech.com .
  • Headquartered in Melville, New York and with a passion for customer success, Comtech designs, produces and markets advanced and secure wireless solutions.

Berkeley Lights to Showcase its New Beacon® System Workflow to Access Broad B Cell Diversity to Rapidly Identify High-Value Rabbit Monoclonal Antibodies at 2022 Antibody Engineering & Therapeutics Conference

Retrieved on: 
수요일, 11월 30, 2022

Berkeley Lights will showcase its Beacon Optofluidic System and single B-cell antibody discovery workflows at AE&T booth #401.

Key Points: 
  • Berkeley Lights will showcase its Beacon Optofluidic System and single B-cell antibody discovery workflows at AE&T booth #401.
  • Anupam Singhal, Ph.D., Director of Product Management, Antibody Discovery at Berkeley Lights will present data on the new Opto Memory B Discovery Rabbit workflow.
  • Abstract: Opto Memory B Discovery Rabbit workflow on the Beacon optofluidic system enables rapid selection of lead candidates by function-forward screening of B cells in under one week.
  • This presentation will introduce Berkeley Lights' newest antibody discovery workflow, the Opto Memory B Discovery workflow, and share how customers are using the workflow to screen rabbit memory B cells to rapidly discover rabbit monoclonal antibodies.

Cemtrex Completes Divestiture of Non-Core Assets to Focus on Accelerating Its Vicon and AIS Brands

Retrieved on: 
화요일, 11월 29, 2022

Brooklyn, NY, Nov. 29, 2022 (GLOBE NEWSWIRE) --  Cemtrex Inc. (NASDAQ: CETX, CETXP), a technology company driving innovation in Internet of Things (IoT), security, machine vision & artificial intelligence, and augmented & virtual reality, today announced that the Company has undertaken a transformative restructuring in which it has divested its Smartdesk and VR subsidiaries in order to focus exclusively on its Vicon Industries and Advanced Industrial Services (AIS) businesses. The restructuring is the culmination of Cemtrex’s previously announced strategic shift towards prioritizing its core businesses.

Key Points: 
  • We believe this shift in focus to capture significant near-term recurring revenue opportunities in Vicon will maximize shareholder value over the next several years.
  • For AIS, the company continues to be a strong source of cash flow with high repeat business and a well-known reputation.
  • As part of the strategic restructuring, on November 22, 2022, Cemtrex completed a divestiture of its Smartdesk, CXR services, Cemtrex Labs, Virtual Driver Interactive and Bravo Strong assets and trade liabilities, allowing Cemtrex to focus on the Vicon and AIS businesses.
  • With the divestments completed, we will be able to drive growth capital to Vicon and focus on a return to profitability.

Ideal Power Enters into Development Agreement with Top 10 Global Automaker for B-TRAN™-based Electric Vehicle Power Module

Retrieved on: 
월요일, 11월 14, 2022

Under this agreement, Ideal Power will partner with this automakers advanced technology development team to develop a custom B-TRAN power module for use in electric vehicle (EV) drivetrain inverters in its next generation EV platform.

Key Points: 
  • Under this agreement, Ideal Power will partner with this automakers advanced technology development team to develop a custom B-TRAN power module for use in electric vehicle (EV) drivetrain inverters in its next generation EV platform.
  • Ideal Power demonstrated that its B-TRAN technology and its value proposition surpassed that of the other contending power device technologies.
  • Under this development program, Ideal Power will also collaborate with an innovative packaging company that will produce the custom B-TRAN modules.
  • We are very excited to engage with another top 10 global automaker and enter into our first B-TRAN development agreement for a custom B-TRAN module, stated Dan Brdar, President and Chief Executive Officer of Ideal Power.

Quanterix to Participate in the 15th Clinical Trials on Alzheimer’s Disease (CTAD) Task Force

Retrieved on: 
수요일, 11월 16, 2022

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced plans to participate in the upcoming 15th Clinical Trials on Alzheimers Disease (CTAD) Task Force in San Francisco, California from November 29 to December 2, 2022.

Key Points: 
  • Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced plans to participate in the upcoming 15th Clinical Trials on Alzheimers Disease (CTAD) Task Force in San Francisco, California from November 29 to December 2, 2022.
  • The Task Force panel will also include perspectives from the pharmaceutical industry and academia.
  • The field of Alzheimers disease diagnostics and therapeutics has become one of the most exciting areas in all of medical research.
  • CTAD is a meeting focused on Alzheimers disease therapeutic trials where key leaders in Alzheimers disease research from industry and academia form partnerships with the goal of speeding the development of effective treatments to fight the disease.

CBRE Ranks Among Top Companies for Investor Transparency

Retrieved on: 
화요일, 11월 15, 2022

CBRE ranked #26 among the S&P 250 for investor transparency and was the top firm within the real estate industry in the fourth annual U.S. Transparency Awards .

Key Points: 
  • CBRE ranked #26 among the S&P 250 for investor transparency and was the top firm within the real estate industry in the fourth annual U.S. Transparency Awards .
  • The rankings compare corporate disclosure practices among the S&P 250the nations largest companies based on market capitalization.
  • CBRE conducts business with the highest integrity and broad disclosure is a key part of delivering exceptional outcomes for all our stakeholders.
  • Specialists from Labrador , a leading global communications firm specializing in corporate disclosure documents, evaluate the annual Proxy Statement, Form 10-K, investor relations website and Code of Conduct of the S&P 250 companies.

Berkeley Lights Accelerating Antibody Discovery with Launch of Rabbit Memory B Cell Workflow

Retrieved on: 
금요일, 11월 18, 2022

EMERYVILLE, Calif., Nov. 18, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (NASDAQ: BLI), a leader in digital cell biology, today announced the launch of the Opto® Memory B Discovery Rabbit workflow, expanding the diversity of antibodies customers can discover on the Beacon® platform.

Key Points: 
  • EMERYVILLE, Calif., Nov. 18, 2022 /PRNewswire/ --Berkeley Lights, Inc. (NASDAQ: BLI), a leader in digital cell biology, today announced the launch of the Opto Memory B Discovery Rabbit workflow, expanding the diversity of antibodies customers can discover on the Beacon platform.
  • The new workflow enables rapid, automated generation of antigen-specific, functional monoclonal antibodies from rabbit memory B cells, building on prior workflows that used mouse plasma B cell samples.
  • This workflow broadens Berkeley Lights' market opportunity beyond mouse workflows, enabling discovery of high-value rabbit antibodiesthat are well-suited for therapeutics, diagnostics and research reagents.
  • While there are currently no robust markers to enrich rabbit plasma B cells, rabbit memory B cells can be readily obtained from blood and easier to source and handle than plasma B cells.

Gulf Resources Announces Rescheduled Conference Call to Discuss Third Quarter 2022 Results on Tuesday, Nov. 15, 2022 at 8:00 a.m. EST

Retrieved on: 
금요일, 11월 11, 2022

Accordingly, the company has rescheduled the call for 8:00 a.m. EST on Tuesday, Nov. 15, before the opening of the market.

Key Points: 
  • Accordingly, the company has rescheduled the call for 8:00 a.m. EST on Tuesday, Nov. 15, before the opening of the market.
  • To participate in this live conference call, please dial Toll Free +1888506-0062 five to ten minutes prior to the scheduled conference call time.
  • International callers should dial +1973-528 - 0011, and please reference to Gulf Resources or Participant Access Code: 105706 while dialing in.
  • Gulf Resources undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.